Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DP0NU9
|
|||
| Drug Name |
AIC100
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Thyroid cancer [ICD-11: 2D10; ICD-10: C73; ICD-9: 193] | Phase 1 | [1] | |
| Company |
AffyImmune Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04420754) Study of AIC100 in Relapsed/Refractory Thyroid Cancer. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of AffyImmune Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.